ACTIMED THERAPEUTICS Trademark

Trademark Overview


On Monday, July 23, 2018, a trademark application was filed for ACTIMED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ACTIMED THERAPEUTICS trademark a serial number of 88049205. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Actimed Therapeutics Limited. The ACTIMED THERAPEUTICS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical, medical and therapeutic substances and preparations; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of cancers, and of severe or chronic illnesses and diseases; pharmaceutical, medical and therapeutic substances and preparations for treatment and management of physical function; pharmaceutical, medical and therapeutic substances and preparations for treatment and prevention of muscle wasting; pharmaceutical, medical and therapeutic substances and preparations for treatment and management of patient tolerance of therapies, in particular anticancer therapy; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of cachexia, in particular cancer cachexia; pharmaceutical, medical and therapeutic substances and preparations for the tre...

Information, advisory and consultancy services relating to medicine and healthcare; medical and surgical diagnosis and treatment services; medical analysis and reporting services relating to the treatment of patients; assessment and monitoring of patients; preparation of data and reports relating to medicine and healthcare; medical testing services relating to the diagnosis and treatment of illnesses, diseases and medical conditions; providing information relating to the management, preparation and dispensing of medications; medical, health, dentistry, veterinary and pharmaceutical services; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to severe or chronic illnesses and diseases; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of cancers, and of severe or chronic illnesses and diseases; medical diagnosis, treatment, testing, analysis, reportin...
actimed therapeutics

General Information


Serial Number88049205
Word MarkACTIMED THERAPEUTICS
Filing DateMonday, July 23, 2018
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6734037
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements


Goods and ServicesPharmaceutical, medical and therapeutic substances and preparations; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of cancers, and of severe or chronic illnesses and diseases; pharmaceutical, medical and therapeutic substances and preparations for treatment and management of physical function; pharmaceutical, medical and therapeutic substances and preparations for treatment and prevention of muscle wasting; pharmaceutical, medical and therapeutic substances and preparations for treatment and management of patient tolerance of therapies, in particular anticancer therapy; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of cachexia, in particular cancer cachexia; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of the side effects of medical treatments, in particular of cancer treatments; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the lung; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the kidney; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the heart; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the liver; pharmaceutical, medical and therapeutic substances and preparations for the treatment and management of severe or chronic illnesses and diseases of the brain; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of chronic heart failure; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of chronic renal failure; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of chronic liver failure; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of chronic obstructive pulmonary disease; pharmaceutical, medical and therapeutic substances and preparations for countering adverse effects of neurological-muscular disorders
Goods and ServicesInformation, advisory and consultancy services relating to medicine and healthcare; medical and surgical diagnosis and treatment services; medical analysis and reporting services relating to the treatment of patients; assessment and monitoring of patients; preparation of data and reports relating to medicine and healthcare; medical testing services relating to the diagnosis and treatment of illnesses, diseases and medical conditions; providing information relating to the management, preparation and dispensing of medications; medical, health, dentistry, veterinary and pharmaceutical services; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to severe or chronic illnesses and diseases; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of cancers, and of severe or chronic illnesses and diseases; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to physical function and muscle wasting; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to patient tolerance of therapies, in particular anticancer therapy; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of cachexia, in particular cancer cachexia; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of the side effects of medical treatments, in particular of cancer treatments; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the lung; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the kidney; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the heart; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the liver; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of severe or chronic illnesses and diseases of the brain; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of chronic heart failure; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of chronic renal failure; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of chronic liver failure; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of chronic obstructive pulmonary disease; medical diagnosis, treatment, testing, analysis, reporting, assessment and monitoring services relating to countering adverse effects of neurological-muscular disorders; advisory, information and consultancy services relating to all the aforesaid services
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 27, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameActimed Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBerkshire SL5 7HL
GB

Party NameActimed Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBerkshire SL5 7HL
GB

Party NameActimed Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBerkshire SL5 7HL
GB

Trademark Events


Event DateEvent Description
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 27, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, January 27, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 27, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, January 27, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, December 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 9, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, October 1, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, October 1, 2021INQUIRY TO SUSPENSION E-MAILED
Friday, October 1, 2021SUSPENSION INQUIRY WRITTEN
Friday, September 24, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, March 2, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 6, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 6, 2020LETTER OF SUSPENSION E-MAILED
Thursday, August 6, 2020SUSPENSION LETTER WRITTEN
Friday, July 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, July 12, 2020ASSIGNED TO LIE
Tuesday, June 30, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 27, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, January 27, 2020INQUIRY TO SUSPENSION E-MAILED
Monday, January 27, 2020SUSPENSION INQUIRY WRITTEN
Tuesday, July 2, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 2, 2019LETTER OF SUSPENSION E-MAILED
Tuesday, July 2, 2019SUSPENSION LETTER WRITTEN
Wednesday, May 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2018NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2018NON-FINAL ACTION WRITTEN
Monday, November 19, 2018ASSIGNED TO EXAMINER
Monday, November 19, 2018ASSIGNED TO EXAMINER
Thursday, November 8, 2018ASSIGNED TO EXAMINER
Friday, July 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 26, 2018NEW APPLICATION ENTERED IN TRAM